FARN vs. FUM, SCLP, 4BB, POLB, REDX, ETX, AVCT, TRX, AREC, and C4XD
Should you be buying Faron Pharmaceuticals Oy stock or one of its competitors? The main competitors of Faron Pharmaceuticals Oy include Futura Medical (FUM), Scancell (SCLP), 4basebio (4BB), Poolbeg Pharma (POLB), Redx Pharma (REDX), e-therapeutics (ETX), Avacta Group (AVCT), Tissue Regenix Group (TRX), Arecor Therapeutics (AREC), and C4X Discovery (C4XD). These companies are all part of the "biotechnology" industry.
Futura Medical (LON:FUM) and Faron Pharmaceuticals Oy (LON:FARN) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings, community ranking, media sentiment and valuation.
37.1% of Futura Medical shares are owned by institutional investors. Comparatively, 12.7% of Faron Pharmaceuticals Oy shares are owned by institutional investors. 33.8% of Futura Medical shares are owned by insiders. Comparatively, 39.3% of Faron Pharmaceuticals Oy shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Faron Pharmaceuticals Oy received 131 more outperform votes than Futura Medical when rated by MarketBeat users. Likewise, 77.51% of users gave Faron Pharmaceuticals Oy an outperform vote while only 64.36% of users gave Futura Medical an outperform vote.
Futura Medical has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500. Comparatively, Faron Pharmaceuticals Oy has a beta of -0.13, suggesting that its share price is 113% less volatile than the S&P 500.
Faron Pharmaceuticals Oy has a net margin of 0.00% compared to Faron Pharmaceuticals Oy's net margin of -210.03%. Futura Medical's return on equity of 0.00% beat Faron Pharmaceuticals Oy's return on equity.
In the previous week, Futura Medical and Futura Medical both had 1 articles in the media. Faron Pharmaceuticals Oy's average media sentiment score of 0.00 equaled Futura Medical'saverage media sentiment score.
Futura Medical has higher revenue and earnings than Faron Pharmaceuticals Oy. Futura Medical is trading at a lower price-to-earnings ratio than Faron Pharmaceuticals Oy, indicating that it is currently the more affordable of the two stocks.
Summary
Futura Medical beats Faron Pharmaceuticals Oy on 7 of the 13 factors compared between the two stocks.
Get Faron Pharmaceuticals Oy News Delivered to You Automatically
Sign up to receive the latest news and ratings for FARN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FARN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Faron Pharmaceuticals Oy Competitors List
Related Companies and Tools
